Results for halofuginon translation from Slovenian to English

halofuginon
halofuginone

halofuginon hidrobromid
halofuginone hydrobromide

halofuginon hidrobromid (stenorol)
halofuginone hydrobromide (stenorol)

halofuginon, baza (v obliki laktata)
halofuginone base (as lactate salt)

glavna sestavina v tkivih je nespremenjeni halofuginon.
unchanged halofuginone is the major component in the tissues.

halofuginon, baza (v obliki laktata) 0,50 mg/ml
halofuginone base (as lactate salt) 0.50 mg/ml

diklazuril, halofuginon, natrijev monenzin, robenidin in maduramicin amonij.
diclazuril, halofuginone, monensin sodium, robenidine and maduramicin ammonium.

halofuginon kot prosta baza je nestabilen v alkalnih in etil acetatnih raztopinah.
halofuginone as the free base is unstable in alkaline and ethyl acetate solutions.

halofuginon kot prosta baza je nestabilen v bazičnih in etilacetatnih raztopinah.
halofuginone as the free base is unstable in alkaline and ethyl acetate solutions.

zdravilna učinkovina zdravila halocur, halofuginon laktat, preprečuje rast cryptosporidium parvum.
the active substance in halocur, halofuginone lactate, prevents the growth of cryptosporidium parvum.

premiksi, ki se uporabljajo v krmi, pri kateri uporaba halofuginon hidrobromida ni dovoljena.
premixtures for use in feed in which the use of halofuginone hydrobromide is not authorised.

diklazuril, halofuginon, natrijev monenzin, robenidin, maduramicin amonij in lasalocid natrij.
diclazuril, halofuginone, monensin sodium, robenidine, maduramicin ammonium and lasalocid sodium.

zdravilna učinkovina halofuginon je antiprotozoik iz skupine derivatov kinazolinona (dušični poliheterocikli).
the active substance, halofuginone, is an antiprotozoal agent of the quinazolinone derivatives group (nitrogenous polyheterocycles).

po ponovnem peroralnem dajanju so koncentracije halofuginon v plazmi primerljive s farmakokinetičnim vzorcem po enkratnem peroralnem dajanju.
the plasmatic concentrations of halofuginone after repeated oral administrations are comparable to the pharmacokinetic pattern after single oral treatment.

zdravilo halocur vsebuje zdravilno učinkovino halofuginon laktat, ki se uporablja proti zajedavskim boleznim, ki jih povzročajo protozoji.
halocur contains the active substance halofuginone lactate, which is used against parasitic diseases caused by protozoa.

za uporabo v krmnih mešanicah, ki vsebujejo kokcidiostatike: diklazuril, halofuginon, monensin natrij in robenidin.
may be used in compounded feed containing coccidiostats: diclazuril, halofuginone, monensin sodium and robenidine.

halofuginon, baza (v obliki laktata) benzojska kislina (e 210) tartrazin (e 102)
halofuginone base (as lactate salt) benzoic acid (e 210) tartrazine (e 102)

uporaba je dovoljena v krmi, ki vsebuje dovoljene kokcidiostatike: diklazuril, halofuginon, robenidin, dekokvinat in narazin/nikarbazin.
the use is permitted in feed containing the permitted coccidiostats: diclazuril, halofuginone, robenidine, decoquinate and narasin/nicarbazin.

halofuginon laktat (ru 38788) je sol, katere učinek proti protozojem in cryptosporidium parvum so dokazali in vitro ter pri umetnih in naravnih okužbah.
halofuginone lactate (ru 38788) is a salt whose antiprotozoal properties and efficacy against cryptosporidium parvum have been demonstrated both in in vitro conditions and in artificial and natural infections.

v delu d "kokcidiostatiki in druge zdravilne snovi", se postavka e 764 "halofuginon" dopolni na naslednji način:
in part d 'coccidiostats and other medicinal substances`, item e 764 'halofuginone` is supplemented as follows: